These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24781824)

  • 1. The ruthenium complexes cis-(dichloro)tetramineruthenium(III) chloride and cis-tetraammine(oxalato)ruthenium(III) dithionate overcome resistance inducing apoptosis on human lung carcinoma cells (A549).
    Vilanova-Costa CA; Porto HK; Pereira Fde C; de Lima AP; Dos Santos WB; Silveira-Lacerda Ede P
    Biometals; 2014 Jun; 27(3):459-69. PubMed ID: 24781824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cell cycle arrest and apoptosis by ruthenium complex cis-(dichloro)tetramineruthenium(III) chloride in human lung carcinoma cells A549.
    de Lima AP; Pereira Fde C; Vilanova-Costa CA; Soares JR; Pereira LC; Porto HK; Pavanin LA; Dos Santos WB; Silveira-Lacerda Ede P
    Biol Trace Elem Res; 2012 Jun; 147(1-3):8-15. PubMed ID: 22144016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1 and cytochrome P450 gene-expression profiles as markers of chemosensitivity in human chronic myelogenous leukemia cells treated with cisplatin and Ru(III) metallocomplexes.
    Vilanova-Costa CA; Porto HK; Pereira LC; Carvalho BP; Dos Santos WB; Silveira-Lacerda Ede P
    Biol Trace Elem Res; 2015 Feb; 163(1-2):39-47. PubMed ID: 25253429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ruthenium complex cis-(dichloro)tetrammineruthenium(III) chloride induces apoptosis and damages DNA in murine sarcoma 180 cells.
    de Lima AP; Pereira Fde C; Vilanova-Costa CA; Ribeiro Ade S; Pavanin LA; Dos Santos WB; Silveira-Lacerda Ede P
    J Biosci; 2010 Sep; 35(3):371-8. PubMed ID: 20826946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and genotoxic effects of cis-tetraammine(oxalato)ruthenium(III) dithionate on the root meristem cells of Allium cepa.
    Pereira Fde C; Vilanova-Costa CA; de Lima AP; Ribeiro Ade S; da Silva HD; Pavanin LA; Silveira-Lacerda Ede P
    Biol Trace Elem Res; 2009 Jun; 128(3):258-68. PubMed ID: 19020813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
    Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
    Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
    Aird RE; Cummings J; Ritchie AA; Muir M; Morris RE; Chen H; Sadler PJ; Jodrell DI
    Br J Cancer; 2002 May; 86(10):1652-7. PubMed ID: 12085218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells.
    Pereira Fde C; de Lima AP; Vilanova-Costa CA; Pires WC; Ribeiro Ade S; Pereira LC; Pavanin LA; Dos Santos WB; Silveira-Lacerda Ede P
    Springerplus; 2014; 3():301. PubMed ID: 25019046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The compound cis-(dichloro)tetrammineruthenium(III) chloride induces caspase-mediated apoptosis in K562 cells.
    de Lima AP; Pereira Fde C; Vilanova-Costa CA; Mello FM; Ribeiro Ade S; Benfica PL; Valadares MC; Pavanin LA; dos Santos WB; Lacerda Ede P
    Toxicol In Vitro; 2010 Sep; 24(6):1562-8. PubMed ID: 20600797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
    Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antitumor studies of organoruthenium complexes with 8-hydroxyquinolines on 2D and 3D cell models of bone, lung and breast cancer.
    Ruiz MC; Kljun J; Turel I; Di Virgilio AL; León IE
    Metallomics; 2019 Mar; 11(3):666-675. PubMed ID: 30839008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
    Brabec V; Nováková O
    Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
    Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The induction of autophagy against mitochondria-mediated apoptosis in lung cancer cells by a ruthenium (II) imidazole complex.
    Chen L; Li G; Peng F; Jie X; Dongye G; Cai K; Feng R; Li B; Zeng Q; Lun K; Chen J; Xu B
    Oncotarget; 2016 Dec; 7(49):80716-80734. PubMed ID: 27811372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A flavonoid isolated from Streptomyces sp. (ERINLG-4) induces apoptosis in human lung cancer A549 cells through p53 and cytochrome c release caspase dependant pathway.
    Balachandran C; Sangeetha B; Duraipandiyan V; Raj MK; Ignacimuthu S; Al-Dhabi NA; Balakrishna K; Parthasarathy K; Arulmozhi NM; Arasu MV
    Chem Biol Interact; 2014 Dec; 224():24-35. PubMed ID: 25289772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ru(pipe)(dppb)(bipy)]PF
    Ferreira-Silva GA; Ortega MM; Banionis MA; Garavelli GY; Martins FT; Dias JSM; Viegas C; Oliveira JC; Nascimento FBD; Doriguetto AC; Barbosa MIF; Ionta M
    Toxicol In Vitro; 2017 Oct; 44():382-391. PubMed ID: 28774850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
    Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
    J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents.
    Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR
    J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.
    Montel AM; Dos Santos RG; da Costa PR; Silveira-Lacerda EP; Batista AA; Dos Santos WG
    Biometals; 2017 Apr; 30(2):295-305. PubMed ID: 28258507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.